Onyx publishes Phase II head and neck cancer data

ONXX published data in Cancer Research from its 37-patient Phase II trial of CI-1042 (ONYX-015), an adenoviral gene therapy targeting tumor cells that lack the p53 gene, as a single agent to treat rec...